Spikevax
Showing 1 - 25 of 28
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran
Recruiting
- SARS-CoV-2
- SPIKEVAX
-
New York, New YorkAetion, Inc
Nov 8, 2023
Risk Factors of Myocarditis and Pericarditis After Moderna
Active, not recruiting
- Myocarditis, Pericarditis
- mRNA-1273
-
Aarhus, Denmark
- +4 more
Oct 31, 2023
Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination
Active, not recruiting
- Coronavirus Disease (COVID-19)
- COVID-19 Vaccine
-
Tokyo, JapanModerna selected site
Jan 12, 2023
Moderna COVID-19 Vaccine in People at High-Risk of Developing
Withdrawn
- Coronavirus Disease (COVID-19)
- COVID-19 Vaccine
-
Tokyo, JapanTakeda Selected Site
Jul 25, 2022
COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)
Active, not recruiting
- COVID-19
- Tozinameran - Standard dose
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital
Aug 24, 2022
COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)
Not yet recruiting
- COVID-19
- Pfizer-BioNTech Standard dose
- +5 more
-
Bandung, West Java, Indonesia
- +2 more
Nov 30, 2022
COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)
Not yet recruiting
- COVID-19
- Tozinameran
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022
Cancer Trial in Anderlecht (Spikevax, Comirnaty)
Recruiting
- Cancer
- Spikevax
- Comirnaty
-
Anderlecht, Belgium
- +1 more
Aug 30, 2022
COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection Trial in Ramat-Gan (mRNA-1273.214 Vaccine, MRNA-1273 Vaccine, Placebo)
Recruiting
- COVID-19 Pandemic
- +3 more
- mRNA-1273.214 Vaccine
- +2 more
-
Ramat-Gan, IsraelSheba Medical Center
Oct 26, 2022
HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA
Recruiting
- HIV
- +5 more
- Pfizer Bivalent COVID-19 Vaccine
- Moderna Bivalent mRNA vaccine
-
Melbourne, Victoria, AustraliaAlfred Health
Jan 31, 2023
Adaptive Immune Response to COVID-19 Vaccination
Active, not recruiting
- SARS-CoV-2 Vaccination
- BNT162b2
- +2 more
-
Greifswald, MV, GermanyUniversity Medicine Greifswald
Mar 25, 2022
COVID-19, Corona Virus Infection Trial in Ann Arbor (Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine)
Recruiting
- COVID-19
- Corona Virus Infection
- Pfizer-BioNTech mRNA COVID-19 vaccine
- Moderna mRNA COVID-19 vaccine
-
Ann Arbor, MichiganUniversity of Michigan
Apr 23, 2022
SafeTy and Efficacy of Preventative CoVID Vaccines
Active, not recruiting
- COVID-19 Virus Infection
- Vaccine Response
- mRNA Vaccines or Viral vector-based vaccines for COVID
-
Toronto, Ontario, CanadaUniversity Health Network
May 19, 2022
Vaccination Reaction, COVID-19, Vaccination; Infection Trial in Cologne (Comirnaty(BTN162b2), Spikevax (mRNA-1273))
Recruiting
- Vaccination Reaction
- +2 more
- Comirnaty(BTN162b2)
- Spikevax (mRNA-1273)
-
Cologne, GermanyUniversity Hospital Cologne
Jan 27, 2022
Covid19 Trial in Santander (Janssen vaccine, Spikevax (Moderna) vaccine)
Not yet recruiting
- Covid19
- Janssen vaccine
- Spikevax (Moderna) vaccine
-
Santander, Cantabria, SpainHospital Universitario Marqués de Valdecilla
Sep 16, 2021
COVID-19 VACCINE, Covid19 Trial in Argentina (COVID-19 vaccines)
Recruiting
- COVID-19 VACCINE
- Covid19
- COVID-19 vaccines
-
Córdoba, Argentina
- +3 more
Sep 24, 2021
COVID-19 Trial in Canada (mRNA-1273 SARS-CoV-2 vaccine, BNT162b2, ChAdOx1-S [recombinant])
Recruiting
- COVID-19
- mRNA-1273 SARS-CoV-2 vaccine
- +4 more
-
Edmonton, Alberta, Canada
- +7 more
Mar 7, 2022
Vaccination; Infection, COVID-19 Trial in Leiden (solid microneedle skin patch, mRNA-1273, standard needle)
Recruiting
- Vaccination; Infection
- COVID-19
- solid microneedle skin patch
- +2 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 14, 2022
COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Italy, Portugal, Spain (COVID-19 Vaccine 40 ug/dose)
Recruiting
- COVID-19
- SARS-CoV-2 Acute Respiratory Disease
- COVID-19 Vaccine 40 ug/dose
-
Milano, Italy
- +19 more
Jul 19, 2022
COVID-19 Trial in Groningen (AKS-452X)
Recruiting
- COVID-19
- AKS-452X
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 19, 2022
Covid19 Trial in United States (CVXGA1 low dose, CVXGA1 high dose)
Recruiting
- Covid19
- CVXGA1 low dose
- CVXGA1 high dose
-
Bardstown, Kentucky
- +3 more
Aug 16, 2022
Menstrual Irregularities and Abnormal Uterine Bleeding After
Completed
- COVID-19
- +3 more
- Covid-19 vaccine
-
Varese, ItalyUniversity of Insubria
Oct 31, 2022
Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster
Terminated
- Anti-SARS-CoV-2 Antibody Response
- blood and saliva samples will be taken
-
Graz, AustriaMedizinische Universität Graz, Klinische Abteilung für Rheumatol
Jan 9, 2023
COVID-19 Respiratory Infection, COVID-19 Vaccine Adverse Reaction Trial in Stockholm (DNA vaccine OC-007, Placebo)
Not yet recruiting
- COVID-19 Respiratory Infection
- COVID-19 Vaccine Adverse Reaction
- DNA vaccine OC-007
- Placebo
-
Stockholm, Region Stockholm, SwedenPhase I Study Unit, Karolinska University Hospital
Jan 13, 2023
Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)
Recruiting
- Rheumatoid Arthritis
- +8 more
- COVID-19 vaccine
-
Montréal, Quebec, Canada
- +1 more
Jan 13, 2023